|
1
|
DNA gyrase genes in Mycobacterium tuberculosis: a single operon driven by multiple promoters.
|
J Bacteriol
|
2002
|
1.35
|
|
2
|
Leaky severe combined immunodeficiency and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation.
|
Blood
|
2009
|
1.19
|
|
3
|
DNA mismatches and GC-rich motifs target transposition by the RAG1/RAG2 transposase.
|
Nucleic Acids Res
|
2003
|
1.05
|
|
4
|
Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivo.
|
J Med Chem
|
2013
|
0.97
|
|
5
|
A hairpin near the 5' end stabilises the DNA gyrase mRNA in Mycobacterium smegmatis.
|
Nucleic Acids Res
|
2002
|
0.83
|
|
6
|
Lead optimization of 1,4-azaindoles as antimycobacterial agents.
|
J Med Chem
|
2014
|
0.82
|
|
7
|
LC-MS based assay to measure intracellular compound levels in Mycobacterium smegmatis: linking compound levels to cellular potency.
|
J Microbiol Methods
|
2013
|
0.82
|
|
8
|
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activity.
|
J Med Chem
|
2014
|
0.82
|
|
9
|
Diarylthiazole: an antimycobacterial scaffold potentially targeting PrrB-PrrA two-component system.
|
J Med Chem
|
2014
|
0.77
|